The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
Clinical trial NCT04233346 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04233346
- Sponsor
- Otsuka Beijing Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2022-07-22
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.